Marco Moschini

Featured in: Favicon

wiley.com (+1) Favicon

mdpi.com

cell.com

europeanurology.com (+1) Favicon

urotoday.com Favicon

cuaj.ca

ejcancer.com Favicon

ejso.com

Articles

Enhanced Recovery After Surgery for patients undergoing Radical Cystectomy: surgeons’ perspectives and recommendations ten years after its implementation

Dec 19, 2024 | ejso.com | Simone Albisinni |Luca Orecchia |Georges Mjaess |Fouad Aoun |Francesco Del Giudice |Luca Antonelli | +10 more

Review ArticleArticles in Press109543 1Urology Unit, Department of Surgical Sciences, Tor Vergata University Hospital, University of Rome Tor Vergata, Rome, Italy 2Department of Urology, Hopital Universitaire de Bruxelles, Universite’ Libre de Bruxelles, Bruxelles, Belgium 3Faculty of Medicine, Hôtel-Dieu de France, Saint-Joseph University, Beirut, Lebanon 4Department of Urology, Policlinico Umberto I, Sapienza University, Rome, Italy 5Department of Urology, Kantonsspital Luzern, Lucerne,...
First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer | Journal of Clinical Oncology

Sep 6, 2024 | brnw.ch | Marco Moschini |Antonio Cigliola |Valentina Tateo

Data Sharing StatementData Sharing StatementData SupplementAuthors retain all rights in any data supplements associated with their articlesThe ideas and opinions expressed in this Data Supplement do not necessarily reflect those of the American Society of Clinical Oncology (ASCO). The mention of any product, service, or therapy in this Data Supplement should not be construed as an endorsement of the products mentioned.
Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Feb 17, 2024 | europeanurology.com | Marco Moschini |Andrea Necchi |Francesco Montorsi

Galsky MD, Daneshmand S, Izadmehr S, et alTo read this article in full you will need to make a paymentSubscribe to European UrologyReferencesEuropean Association of Urology guidelines on muscle-invasive and metastatic bladder cancer: summary of the 2020 guidelines. Eur Urol.
Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study

Mar 24, 2023 | europeanurology.com | Marco Moschini |Andrea Salonia |Alberto Briganti |Francesco Montorsi

Results from HIVEC-II for Intermediate-risk Non–muscle-invasive Bladder Cancer: Is This a Dead End for Mitomycin C Hyperthermia?
Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer

Feb 16, 2023 | europeanurology.com | Mario de Angelis |Alberto Briganti |Francesco Montorsi |Marco Moschini

• None Maintenance versus non-maintenance intravesical bacillus Calmette-Guerin instillation for non-muscle invasive bladder cancer: a systematic review and meta-analysis of randomized clinical trials. :• None Impact of enhanced optical techniques at time of transurethral resection of bladder tumour, with or without single immediate intravesical chemotherapy, on recurrence rate of non-muscle-invasive bladder cancer: a systematic review and network meta-analysis of randomized trials. :
Re: Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A P

Feb 16, 2023 | europeanurology.com | Marco Moschini |Francesco Montorsi

To read this article in full you will need to make a payment
The Impact and Evaluation of Lynch Syndrome on Upper Tract Urothelial Carcinoma - Marco Moschini

Feb 7, 2023 | urotoday.com | Marco Moschini

Read the Full Video TranscriptSam Chang: Hello everyone, my name is Sam Chang. I am a urologist at Vanderbilt University in Nashville, Tennessee. And we are very fortunate to have Dr. Marco Moschini from Milan, Italy. He's a full-staff urologist there, MD, PhD. And importantly, part of the young urologist group within the EAU that's examined the impact and the disease process of Lynch syndrome and the evaluation for upper tract urothelial carcinoma for these patients.

Contact details

Emails

[email protected]

Socials & Sites

Try JournoFinder For Free

Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.

Start Your 7-Day Free Trial →

Marco Moschini

Articles

Enhanced Recovery After Surgery for patients undergoing Radical Cystectomy: surgeons’ perspectives and recommendations ten years after its implementation

First Results of NURE-Combo: A Phase II Study of Neoadjuvant Nivolumab and Nab-Paclitaxel, Followed by Postsurgical Adjuvant Nivolumab, for Muscle-Invasive Bladder Cancer | Journal of Clinical Oncology

Re: Gemcitabine and cisplatin plus nivolumab as organ-sparing treatment for muscle-invasive bladder cancer: a phase 2 trial

Re: Clinical Efficacy of Neoadjuvant Intravesical Mitomycin-C Therapy Immediately Before Transurethral Resection of Bladder Tumor in Patients with Nonmuscle-invasive Bladder Cancer: Preliminary Results of a Prospective, Randomized Phase II Study

Re: A Randomized Trial of PHOTOdynamic Surgery in Non-muscle-invasive Bladder Cancer

Re: Outpatient Photodynamic Diagnosis-guided Laser Destruction of Bladder Tumors Is as Good as Conventional Inpatient Photodynamic Diagnosis-guided Transurethral Tumor Resection in Patients with Recurrent Intermediate-risk Low-grade Ta Bladder Tumors. A P

The Impact and Evaluation of Lynch Syndrome on Upper Tract Urothelial Carcinoma - Marco Moschini

Contact details

Emails

Socials & Sites